FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006704976> ?p ?o ?g. }

• W3006704976 endingPage "e0227552" @default.
• W3006704976 startingPage "e0227552" @default.
• W3006704976 abstract "Background Among prostate cancer (PC) patients, over 90% of distant metastases occur in the bone. PC treatments may be associated with side effects, including second primary malignancies (SPM). There is limited information on the incidence of SPM among men with bone metastatic PC (mPC) and among men with bone metastatic castration-resistant PC (mCRPC). We estimated overall survival and the incidence of SPM in men with mPC and mCRPC. Methods In the Prostate Cancer data Base Sweden, the National Prostate Cancer Register was linked to other national health care registers, 15,953 men with mPC in 1999–2011 were identified. Further, 693 men with mCRPC were identified. Outcomes were evaluated using stratified incidence rates, Kaplan-Meier estimators and Cox models. Results The mean age among men with mPC was 73.9 years and in men with mCRPC 70.0 years. The median respective survivals were 1.5 (13,965 deaths) and 1.14 years (599 deaths), and average times since PC diagnosis 1.8 and 4.7 years. We observed 2,669 SPMs in men with mPC and 100 SPMs in men with mCRPC. The incidence rate of SPM per 1,000 person-years was 81.8 (78.8–85.0) for mPC and 115.6 (95.1–140.7) for mCRPC. High age, prior neoplasms, urinary tract infection, congestive heart failure, diabetes and renal disease were most strongly associated with increased mortality risk. Prior neoplasms and prior use of antineoplastic agents were most strongly associated with increased SPM risk. Several factors associated with increased mortality and SPM risks were more prevalent in the mCRPC cohort. Conclusions Our results on mortality for men with mPC and mCRPC are in line with previous studies from the same time period. Investigation of factors associated with mortality and SPM in men with mPC and mCRPC can help to further understand these outcomes in the era prior to several new treatments have come available." @default.
• W3006704976 created "2020-03-06" @default.
• W3006704976 creator A5001950915 @default.
• W3006704976 creator A5010401322 @default.
• W3006704976 creator A5023687459 @default.
• W3006704976 creator A5031838211 @default.
• W3006704976 creator A5071438959 @default.
• W3006704976 creator A5086734973 @default.
• W3006704976 creator A5091544789 @default.
• W3006704976 date "2020-02-21" @default.
• W3006704976 modified "2023-10-11" @default.
• W3006704976 title "Overall survival and second primary malignancies in men with metastatic prostate cancer" @default.
• W3006704976 cites W1797512951 @default.
• W3006704976 cites W1904433804 @default.
• W3006704976 cites W1914523354 @default.
• W3006704976 cites W1970345836 @default.
• W3006704976 cites W1978764883 @default.
• W3006704976 cites W1981525998 @default.
• W3006704976 cites W2004278647 @default.
• W3006704976 cites W2009825110 @default.
• W3006704976 cites W2026102934 @default.
• W3006704976 cites W2029125073 @default.
• W3006704976 cites W2045101532 @default.
• W3006704976 cites W2048761127 @default.
• W3006704976 cites W2080439368 @default.
• W3006704976 cites W2082541377 @default.
• W3006704976 cites W2108157371 @default.
• W3006704976 cites W2110534364 @default.
• W3006704976 cites W2123230901 @default.
• W3006704976 cites W2124215313 @default.
• W3006704976 cites W2134591303 @default.
• W3006704976 cites W2135492571 @default.
• W3006704976 cites W2137467802 @default.
• W3006704976 cites W2141454098 @default.
• W3006704976 cites W2158004742 @default.
• W3006704976 cites W2166918329 @default.
• W3006704976 cites W2167331614 @default.
• W3006704976 cites W2168242827 @default.
• W3006704976 cites W2169557289 @default.
• W3006704976 cites W2171527434 @default.
• W3006704976 cites W2294907556 @default.
• W3006704976 cites W2340534380 @default.
• W3006704976 cites W2464502417 @default.
• W3006704976 cites W4298017640 @default.
• W3006704976 doi "https://doi.org/10.1371/journal.pone.0227552" @default.
• W3006704976 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7034858" @default.
• W3006704976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32084147" @default.
• W3006704976 hasPublicationYear "2020" @default.
• W3006704976 type Work @default.
• W3006704976 sameAs 3006704976 @default.
• W3006704976 citedByCount "15" @default.
• W3006704976 countsByYear W30067049762020 @default.
• W3006704976 countsByYear W30067049762021 @default.
• W3006704976 countsByYear W30067049762022 @default.
• W3006704976 countsByYear W30067049762023 @default.
• W3006704976 crossrefType "journal-article" @default.
• W3006704976 hasAuthorship W3006704976A5001950915 @default.
• W3006704976 hasAuthorship W3006704976A5010401322 @default.
• W3006704976 hasAuthorship W3006704976A5023687459 @default.
• W3006704976 hasAuthorship W3006704976A5031838211 @default.
• W3006704976 hasAuthorship W3006704976A5071438959 @default.
• W3006704976 hasAuthorship W3006704976A5086734973 @default.
• W3006704976 hasAuthorship W3006704976A5091544789 @default.
• W3006704976 hasBestOaLocation W30067049761 @default.
• W3006704976 hasConcept C120665830 @default.
• W3006704976 hasConcept C121332964 @default.
• W3006704976 hasConcept C121608353 @default.
• W3006704976 hasConcept C126322002 @default.
• W3006704976 hasConcept C143998085 @default.
• W3006704976 hasConcept C2776235491 @default.
• W3006704976 hasConcept C2780192828 @default.
• W3006704976 hasConcept C50382708 @default.
• W3006704976 hasConcept C61511704 @default.
• W3006704976 hasConcept C71924100 @default.
• W3006704976 hasConceptScore W3006704976C120665830 @default.
• W3006704976 hasConceptScore W3006704976C121332964 @default.
• W3006704976 hasConceptScore W3006704976C121608353 @default.
• W3006704976 hasConceptScore W3006704976C126322002 @default.
• W3006704976 hasConceptScore W3006704976C143998085 @default.
• W3006704976 hasConceptScore W3006704976C2776235491 @default.
• W3006704976 hasConceptScore W3006704976C2780192828 @default.
• W3006704976 hasConceptScore W3006704976C50382708 @default.
• W3006704976 hasConceptScore W3006704976C61511704 @default.
• W3006704976 hasConceptScore W3006704976C71924100 @default.
• W3006704976 hasIssue "2" @default.
• W3006704976 hasLocation W30067049761 @default.
• W3006704976 hasLocation W30067049762 @default.
• W3006704976 hasLocation W30067049763 @default.
• W3006704976 hasLocation W30067049764 @default.
• W3006704976 hasLocation W30067049765 @default.
• W3006704976 hasLocation W30067049766 @default.
• W3006704976 hasOpenAccess W3006704976 @default.
• W3006704976 hasPrimaryLocation W30067049761 @default.
• W3006704976 hasRelatedWork W1580426574 @default.
• W3006704976 hasRelatedWork W1980245127 @default.
• W3006704976 hasRelatedWork W2089620537 @default.
• W3006704976 hasRelatedWork W2275480158 @default.
• W3006704976 hasRelatedWork W2371214482 @default.

• next